Esperion Therapeutics | ESPR - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 364.22B 20.46B 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Alterity Therapeutics Limited AUD 40M 16M 2026-05
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Cipla INR 1.15T 162.77B 2026-05
CSL USD 55.89B 20.42B 2025-12
Cytokinetics USD 9.16B 975M 2026-05
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Geron USD 946M 9M 2026-05
Halozyme Therapeutics USD 8.56B 905M 2026-05
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12